DENTAL CARE IMPROVEMENTS USING INFORMATICS AND ARTIFICIAL INTELLIGENCE
Professor Heiko Spallek
Head of School and Dean of The University of Sydney School of Dentistry &
Member of Scientific Advisory Committee, Dentroid
RESEARCHER PROFILE
Filmed in Sydney, Australia | December 2024
Professor Heiko Spallek is the Head of School and Dean of the Sydney Dental School, as well as a member of the Scientific Advisory Committee for Dentroid, a startup in Australia aiming to revolutionise dentistry with laser technology. He has gained extensive experience in various roles at research-intensive institutions across three different continents.
Professor Spallek advanced his dental knowledge by studying computer information science in the US, particularly in Philadelphia. He conducted research for 20 years in the US at the intersection of dentistry and informatics.
As the Dean of Dentistry, he remains involved with a group in the US focused on improving dental care through informatics and artificial intelligence. In Australia, he finds the opportunity to work with Dentroid particularly engaging, as the startup seeks to enhance dental care by eliminating needles and drills to reduce patient discomfort.
Professor Spallek notes that there haven’t been significant changes in dentistry over the past few decades, aside from incremental improvements. He finds it both challenging and interesting to address the stagnation in the field, despite the availability of better materials in dentistry.
He points out that traditional dental treatments still heavily rely on local anaesthesia administered through long needles, as well as high-pitched noises and vibrations from hand pieces, which create discomfort for patients. Furthermore, dentists often have to hunch over patients’ mouths, exposing themselves to infectious spray.
Dentroid is attempting to create a paradigm shift by starting treatments with a light-induced analgesic, followed by a small robot that clamps onto the tooth, removing tissue without the need for drilling through laser technology. This procedure is guided and controlled by the dentist from a desk. Professor Spallek collaborates with researchers from four leading institutions in Australia to bring this new vision to life.
Outside of his professional responsibilities, Professor Spallek prioritises his family and serves as a volunteer director for Community Connections Australia. This organisation offers a range of tailored services to individuals living with disabilities. With the support of a management team, their 150 frontline workers assist approximately 300 clients in achieving greater independence in their homes.
You Might also like
-
CASE STUDY Large scale genetic study finds link between Irritable Bowel Syndrome & cardiovascular system
Research published April 2024 in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD).
-
Radiation therapy techniques and combination treatments for sarcoma
Professor Angela Hong MBBS, MMed, PhD, FRANZCR is a Professor at Sydney Medical School of the University of Sydney. She is a radiation oncologist and has been a member of the Multidisciplinary Bone and Soft Tissue Tumour Clinic at Royal Prince Alfred Hospital/Chris O’Brien Lifehouse for the past 15 years.
As a radiation oncologist located in Sydney, Australia, Professor Hong is focused on treating patients with bone and soft tissue sarcoma. And as a clinician scientist, her research focuses on developing innovative radiation therapy technique and combination treatments to improve the outcome for patients with sarcoma.
-
CASE STUDY Role of Exercise in Metabolic Associated Fatty Liver Disease
Dr. Shelley Keating AES AEP* is an Accredited Exercise Physiologist, a researcher, and a senior lecturer at the School of Human Movement and Nutrition Sciences at the University of Queensland in Brisbane, Australia. Dr. Keating’s research primarily focuses on the role of exercise in the management of metabolic dysfunction associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease. MASLD affects a significant portion of the global adult population, with many individuals unaware of their condition.